Pfizer Inc (NYSE:PFE) reported better-than-expected fourth quarter 2025 earnings on February 3, 2026, with adjusted diluted EPS of $0.66 exceeding analyst expectations of $0.58 by 13.79%. Despite the ...

PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that preclinical data on ARO-INHBE, an investigational RNAi-based medicine for the treatment of ...

In many rural Arkansas counties, access to healthy food, nutrition education and safe places for physical activity are limited, contributing to higher rates of obesity. To help improve these ...

Shares of several obesity-focused stocks dropped on Wednesday after Swiss pharma giant Roche RHHBY announced positive top-line results from an early-stage study on its experimental obesity drug CT-996 ...

Obesity now affects more than one in five children in the United States, and while there are effective, recommended interventions, availability is limited for most children. In two new studies, Yale ...

BOSTON--(BUSINESS WIRE)--Today, Form Health, the leading provider of science-based obesity care in the United States, announced a new program to prevent progression from overweight to obesity.

PALO ALTO, Calif.--(BUSINESS WIRE)--Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced ...

Paul L. Berns, Chief Executive Officer, stated that Neumora "prioritized obesity as the lead indication for NMRA-215, our highly brain-penetrant NLRP3 inhibitor." He outlined, "We expect to have up to ...